Posted inBiotechnology
GSK catches phase 3 fever after mRNA flu vaccine beats standard shots
GSK has linked its mRNA seasonal flu vaccine candidate to higher immune responses than conventional jabs in a phase 2…
Posted inMedical Technology
Medtronic recalls reflux monitoring device as 184 serious injuries linked to capsule
Medtronic is recalling certain esophageal pH monitoring capsule delivery devices amid risks of them failing whilst deployed.
Posted inMedical Technology
Boston Scientific halts sales of angiographic catheters amid ‘two serious injuries’
Boston Scientific has told its customers to stop using its Imager II angiographic catheters upon learning that a manufacturing issue…
Posted inGenetics
Spatial Transcriptomics Tools May Link Tumor Organization to Treatment Response
Credit: Marcin Klapczynski/Getty Images Spatial transcriptomics has given cancer researchers a powerful way to see not only which genes are…
Posted inGenetics
Single-Use Comes of Age—What Comes Next?
Credit: Extreme Photographer/Getty Images For much of the past two decades, the biopharmaceutical industry has assessed single-use technologies in terms…
Posted inGenetics
‘One-Two Punch’ Targets Resistance Mechanism in Aggressive Triple-Negative Breast Cancer
Credit: NEMES LASZLO/Science Photo Library/ Getty Images Triple-negative breast cancer (TNBC) may initially respond well to chemotherapy but will often…
Posted inBiotechnology
Novartis, Bristol Myers halt autoimmune CAR-T trials due to adverse events
Novartis and Bristol Myers Squibb have halted several CAR-T trials in autoimmune diseases due to immune-related adverse events, Fierce has…
Posted inGenetics
Key Immune Cells Identified That Could Strengthen Flu Vaccines
Credit: urfinguss / iStock / Getty Images Plus Influenza continues to be a major source of illness in the United…
Posted inGenetics
Darpa Awards UC San Diego Up to $11.3 Million for ‘Smarter’ Red Blood Cells
Credit: Koto Feja/Getty Images Scientists at the University of California San Diego School of Medicine have been awarded a contract…
Posted inBiotechnology
ESC: Alnylam’s next-gen silencer sees silver linings after fallout of AZ, Ionis trial in ATTR-CM
As AstraZeneca appears to close the book on a combo approach following the phase 3 failure of its Ionis-partnered Wainua,…